Literature DB >> 32103171

Treat phage like living antibiotics.

Robert T Schooley1, Steffanie Strathdee2.   

Abstract

Mesh：

Substances：

Year:  2020        PMID： 32103171     DOI： 10.1038/s41564-019-0666-4

Source DB:  PubMed          Journal:  Nat Microbiol        ISSN： 2058-5276            Impact factor:   17.745


× No keyword cloud information.
  5 in total

1.  Coevolutionary phage training leads to greater bacterial suppression and delays the evolution of phage resistance.

Authors:  Joshua M Borin; Sarit Avrani; Jeffrey E Barrick; Katherine L Petrie; Justin R Meyer
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-08       Impact factor: 11.205

2.  Lessons Learned From the First 10 Consecutive Cases of Intravenous Bacteriophage Therapy to Treat Multidrug-Resistant Bacterial Infections at a Single Center in the United States.

Authors:  Saima Aslam; Elizabeth Lampley; Darcy Wooten; Maile Karris; Constance Benson; Steffanie Strathdee; Robert T Schooley
Journal:  Open Forum Infect Dis       Date:  2020-08-27       Impact factor: 3.835

3.  A Mycobacteriophage-Based Vaccine Platform: SARS-CoV-2 Antigen Expression and Display.

Authors:  Krista G Freeman; Katherine S Wetzel; Yu Zhang; Kira M Zack; Deborah Jacobs-Sera; Sara M Walters; Dominique J Barbeau; Anita K McElroy; John V Williams; Graham F Hatfull
Journal:  Microorganisms       Date:  2021-11-23

4.  Phage Therapy Related Microbial Succession Associated with Successful Clinical Outcome for a Recurrent Urinary Tract Infection.

Authors:  Austen Terwilliger; Justin Clark; Maile Karris; Haroldo Hernandez-Santos; Sabrina Green; Saima Aslam; Anthony Maresso
Journal:  Viruses       Date:  2021-10-12       Impact factor: 5.048

5.  The Future of Bacteriophage Therapy Will Promote Antimicrobial Susceptibility.

Authors:  Olivia Williams Barber; Iria Mañas Miramontes; Manu Jain; Egon A Ozer; Erica M Hartmann
Journal:  mSystems       Date:  2021-07-20       Impact factor: 6.496
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.